University of Kentucky

UKnowledge
Internal Medicine Faculty Publications

Internal Medicine

7-26-2018

Gut Inflammatory Diseases, Infection, and Nutrition
Helieh S. Oz
University of Kentucky, ulas.oz@uky.edu

Sung-Ling Yeh
Taipei Medical University, Taiwan

Amedeo Amedei
University of Florence, Italy

Follow this and additional works at: https://uknowledge.uky.edu/internalmedicine_facpub
Part of the Immunology and Infectious Disease Commons, and the Nutrition Commons

Right click to open a feedback form in a new tab to let us know how this document benefits you.
Repository Citation
Oz, Helieh S.; Yeh, Sung-Ling; and Amedei, Amedeo, "Gut Inflammatory Diseases, Infection, and Nutrition"
(2018). Internal Medicine Faculty Publications. 144.
https://uknowledge.uky.edu/internalmedicine_facpub/144

This Editorial is brought to you for free and open access by the Internal Medicine at UKnowledge. It has been
accepted for inclusion in Internal Medicine Faculty Publications by an authorized administrator of UKnowledge. For
more information, please contact UKnowledge@lsv.uky.edu.

Gut Inflammatory Diseases, Infection, and Nutrition
Digital Object Identifier (DOI)
https://doi.org/10.1155/2018/7160859

Notes/Citation Information
Published in Mediators of Inflammation, v. 2018, article ID 7160859, p. 1-4.
Copyright © 2018 Helieh S. Oz et al.
This is an open access article distributed under the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.

This editorial is available at UKnowledge: https://uknowledge.uky.edu/internalmedicine_facpub/144

Hindawi
Mediators of Inﬂammation
Volume 2018, Article ID 7160859, 4 pages
https://doi.org/10.1155/2018/7160859

Editorial
Gut Inflammatory Diseases, Infection, and Nutrition
Helieh S. Oz ,1 Sung-Ling Yeh ,2 and Amedeo Amedei

3

1

University of Kentucky Medical Center, Lexington, USA
Taipei Medical University, Taipei, Taiwan
3
University of Florence, Florence, Italy
2

Correspondence should be addressed to Helieh S. Oz; hoz2@email.uky.edu
Received 24 June 2018; Accepted 24 June 2018; Published 26 July 2018
Copyright © 2018 Helieh S. Oz et al. This is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

There is a strong link between inﬂammation, infectious
agents, and nutritional status. Millions of people suﬀer from
chronic inﬂammatory diseases, and the incidence has significantly increased in recent years. Inﬂammation is a multifactorial biological and immunological response to diﬀerent
injuries. Inﬂammation is initiated by several stimuli such as
pathogens, chemical irritants, nutritional imbalance, and
diﬀerent cell injures. Inﬂammation is required in the body
process of healing. But, chronic inﬂammation can cause
severe and irreversible complications. Diﬀerent chronic
inﬂammatory diseases include hepatic, colitis, gastrointestinal, and neurodegenerative. Divers microbial (e.g., Helicobacter, Campylobacter, Clostridium, and Mycobacterium),
parasitic (e.g., protozoa, helminthes, and ﬂatworms), and
viral (HPV, norovirus, and hepatitis B and C) are linked with
chronic inﬂammatory responses. Additionally, nutrition
imbalance and speciﬁc nutrients may inﬂuence immune
response, modulating infections, and inﬂammatory responses.
Crohn’s and ulcerative colitis are chronic inﬂammatory
bowel disease (IBD) and progressive complication with a
dysregulated gastrointestinal mucosal immune response in
patient toward intestinal microbiota. Pediatrics often manifest with more severe Crohn’s complication than adults.
Crohn’s patients may eventually develop strictures and
malignancies. IL-17-A-producing T helper cells (Th17) have
a key role in provoking progression of disease by production
of proinﬂammatory cytokines which in turn required for
regeneration and protection of epithelial cells. Crohn’s
patients have increased production of IL-17 by T helper cells
and higher IL-17 mRNA expression at the mucosal level
and increased numbers of Th17 cells are associated with

endoscopic deﬁnition of disease activity. Unlike previous
studies, A. Dige et al. concluded that anti-TNFα antibody
therapy has no eﬀect on the mucosal levels of IL-17A,
IL-21, and IL-22 or LP T cell production during early treatment (ﬁrst 4 weeks) in Crohn’s disease.
Composition of commensal microbiota can inﬂuence
autoimmune disease progress and persistence. The intestinal
microbiota is involved in triggering the immune system and
leading to intestinal inﬂammation. IBD patients suﬀer from
a dysbiosis, with decrease in diversity and abundance of some
beneﬁcial commensal bacteria. For instance, signiﬁcant
reductions have been reported in Biﬁdobacteria and Lactobacillus in the IBD patients’ fecal content suggesting a therapeutic application to normalize the gut ﬂora in autoimmune
patients using probiotics. Recent study report that gut microbial can translocate from gut into the organs as gut barrier
compromises and pathogenic T helper cells are evident in
the gut, liver, and lymphoid organs. Similarly, microbial are
also found in hepatic biopsies of autoimmune patients and
not in healthy counterparts. Biﬁco is a probiotic mixture of
Lactobacillus, Biﬁdobacterium, and Enterococcus. Previous
studies have demonstrated Biﬁco to improve colitis and
colitis-associated malignancy, pouchitis, diarrhea, and gastritis in models. In addition, clinical trials have revealed therapeutic application for Biﬁco in Crohn’s and ulcerative
colitis patients. Biﬁco has been shown to elevate the
expression of colonic TJs and promote intestinal epithelial
barrier function in IL-10-deﬁcient mice. In vitro experiments also showed that Biﬁco, or single probiotic strains
(Biﬁdobacterium, Lactobacillus, or Enterococcus), increases
transepithelial electrical resistance and the expression of
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TJs in Escherichia coli-treated Caco-2 monolayers. Biﬁco
signiﬁcantly inhibited the secretion of proinﬂammatory
cytokines and reduced bacterial invasion and combination
of probiotics were more pronounced than single-strain probiotics. Biﬁco was shown to have anti-inﬂammatory eﬀect
to expand Tregs in mesenteric lymph nodes and disturbance
of Th1/Th2 cytokines in the colonic mucosa of TNBSinduced colitis mice. However, the eﬀect of Biﬁco on the
Tregs in intestinal tissue and peripheral blood has not been
reported. These experimental studies were performed in
active colitis induced with dextran sulfate sodium (DSS) to
explore the therapeutic eﬀects of Biﬁco. Here, Y. Zhang
et al. used DSS-active colitis model to investigate Biﬁco eﬀect
associated with local and systemic immune responses. This
study explored the protective eﬀect of Biﬁco pretreating on
subsequent intestinal inﬂammation.
Acute pancreatitis (AP) is an acute and life-threatening
inﬂammatory disease that commonly damages peripancreatic tissues and other distant organs. A consistent percentage
(about the 25%) of patients with severe acute pancreatitis
(SAP) develops into infected pancreatic necrosis and persistent organ failure, contributing the most to AP mortality.
In fact the SAP, due to excessive release of inﬂammatory
factors and increased oxidative stress response, can cause
distant organ damage, especially acute lung injury. In addition, currently, there is no eﬀective therapeutic strategy for
AP. For this purpose, Y. Li et al. used Cae-induced mild AP
(MAP) model and L-arginine-induced SAP model, to
investigate the role of naringenin (Nar) in AP and the
accompanying organ dysfunctions in mice as well as the
underlying mechanisms. Nar is a type of ﬂavonoid, with
anti-inﬂammatory properties, organ-protective eﬀects, and
antioxidative functions. They observed that the serum levels
of amylase, lipase, and cytokines and the malondialdehyde
(MDA) levels of pancreatic tissue were signiﬁcantly decreased
in both MAP and SAP models after Nar treatment. In
contrast, glutathione peroxidase, glutathione reductase,
glutathione-S-transferase, total sulfhydryl, and nonprotein
sulfhydryl were markedly increased both in MAP and SAP
after Nar treatment. In addition, the injury in pancreatic
and pulmonary tissues was markedly improved as evidenced
by the inhibited expression of myeloperoxidase, nod-like
receptor protein 3, and interleukin-1β as well as the enhanced
expression of nuclear factor erythroid 2-related factor2/heme
oxygenase-1 in pancreatic tissues. So, they concluded that
Nar exerted protective eﬀects on Cae-induced MAP and
L-arginine-induced SAP in mice, suggesting that Nar may
be a potential therapeutic intervention for AP.
Gut microbiota (GM) plays several crucial roles in host
physiology, inﬂuencing diﬀerent relevant functions. GM
diversity is aﬀected by diet and inﬂuences metabolic and
immune functions of the host’s physiology. Consequently, a
dysbiosis may be the cause or at least may lead to the progression of various pathologies such as infectious diseases, gastrointestinal cancers, IBD, and even obesity and diabetes.
Therefore, GM is an appropriate target for nutritional
intervention to improve health and phytochemicals (that
can inﬂuence GM) have recently been studied as adjuvants
for the treatment of obesity and inﬂammatory diseases.

Mediators of Inﬂammation
L. Carrera-Quintanar et al. discussed the most recent evidence indicating a relationship between the eﬀects of diﬀerent
phytochemicals and gut microbiota, aﬀecting obesity and/or
inﬂammation. Authors focused on the eﬀect of approximately
40 diﬀerent phytochemical compounds, candidates for the
treatment of obesity and inﬂammatory diseases. They concluded that several issues need to be resolved before natural
products can be eﬀectively translated into the clinic. With
regard to the best source of bioactive molecules, the following aspects should be considered: (a) whether it is better to
acquire them directly from diet food or from pharmacological sources and (b) whether they should be used alone or
as a cotreatment in combination with approved drugs.
Therefore, it is urgent to develop speciﬁc clinical trials. In
addition, disadvantages of commercial nutraceutics’ preparations include the high variability in formulations, as well
as the dosage quantiﬁcation and the diﬀerent means of
administration. Finally, critical investigations are required
to optimize these phytochemical formulation and dosages
for possible future administration.
The digestive system plays an important part in pathogenesis of infection by the human immunodeﬁciency virus
(HIV), which can infect hepatocytes, Kupﬀer cells, and
hepatic stellate cells, inducing the production of inﬂammatory cytokines and favoring hepatic steatosis. Circulating
levels of diﬀerent hepatic proteins (e.g., albumin, prealbumin,
and transferrin) decrease, increasing the mortality risk in
AIDS patients. L. Xu et al. evaluated whether the level of
butyrylcholinesterase (BchE) could be associated with the
progression/prognosis of AIDS patients. Evaluating a cohort
of 505 patients, the associations between BChE level and CD4
count, WHO stage, body mass index, and C-reactive protein
level, the authors concluded that BChE level is associated
with HIV/AIDS severity and is an independent risk factor
for increased mortality in AIDS patients.
Surgery is elective treatment for colorectal malignancy,
yet the morbidity rate following colorectal resection remains
as high as 24%–43%. Some of these postsurgical complications include tissue adhesions at the site of surgery, infections, anastomotic leakage, impaired bowel movement, and
malfunction as transient or prolonged postsurgical ileus if
not resolved after 5 days or recurrent after recovery. These
complications can delay recovery and increase the length
of hospitalization and acquired infections and medical
expenses. An eﬀective biomarker to predict postsurgical ileus
and other complications can be useful for recovery in these
patients. G.S.A. Boersema et al. investigated a prospective
cohort trail for the association between the inﬂammatory
cytokines and the postoperative complications. The authors
studied 47 patients from which 34 (72%) recovered. From
13 patients (28%) who developed postsurgical ileus, 8 (20%)
recovered after 5 days and 5 patients (10%) developed
recurrent disease. The authors discuss the association of
diﬀerent inﬂammatory cytokines involvement with postsurgical complications and reason IL-6 changes to predict the
infectious complications but not postsurgical ileus after
colorectal surgery. They concluded that IL-6 may be promising candidate to assist an early detection of the infections
following surgeries.

Mediators of Inﬂammation
Maresins, a group of lipid mediators, are biosynthesized from docosahexaenoic acid which displays strong
anti-inﬂammatory and proresolving activity. Resolution of
inﬂammation is an active and highly regulated cellular and
biochemical process required to protect against inﬂammatory complications. S. Tang et al. review the biological
actions, pathways, and mechanisms of maresins and their
roles in the resolution of inﬂammation in various disease
conditions including lung disease, vascular disease, obesity,
diabetes, and IBD. Authors concluded that maresins may
prevent neutrophil inﬁltration, enhance macrophage phagocytosis, inhibit nuclear factor-κB activation, and stimulate
tissue regeneration. Similar studies may provide new directions to discover maresin-related stable analogues to control
inﬂammation in the future.
IBD is a multifactorial inﬂammatory disease of the intestine. Diet has long been suspected to contribute to the IBD
development and the Western dietary pattern, which is high
fat, high n-6 polyunsaturated fatty acids (PUFA), is associated with an increased IBD risk. N-3 PUFAs contain mostly
ﬁsh oil and have anti-inﬂammatory properties. C. Charpentier
et al. investigated the dietary inﬂuence of fatty acid composition on 2,4,6-trinitrobenzen sulfonic acid- (TNBS-) induced
colitis. Rats were fed with diets varying in n-3/n-6/n-9 ratio
to reproduce dietary pattern from a pragmatic to a Western
diet. There were 4 groups with n-3/n-6/n-9 ratio 1 : 4 : 16,
1 : 1 : 4, 1 : 16 : 16, and 1 : 4 : 24, respectively. n-3/n-6/n-9 ratio
1 : 4 : 16 is recommended as a well-balanced control diet, and
1 : 1 : 4 was a target by dietary advice in a Japanese clinical
trial for IBD patients. 1 : 16 : 16 is considered comparable
to Western diet, and ratio 1 : 4 : 24 is comparable to the
Mediterranean diet. The results showed that compared to
the control diet, n-3 polyunsaturated fatty acids-rich diet
signiﬁcantly decreased colon-inducible nitric oxide synthase, cycloxygenase-2 expression, IL-6, and leukotriene
B4 production. The authors concluded that n-3 diet group
which showed n-3/n-6 ratio equals to 1 attenuated inﬂammatory markers in the colon that may contribute to partially limit colitis genesis.
Formononetin is an isoﬂavone compound that has been
reported to possess anti-inﬂammatory properties. D. Wu
et al. investigated the eﬀects of formononetin on DSSinduced acute colitis in vivo and in vitro on tumor necrosis
factor-α-induced human colonic cell injury models. Mice
with colitis were intraperitoneal injected with diﬀerent dosages of formononetin. The main ﬁndings showed that formononetin administration relieved clinical symptoms of colitis,
mitigated colonic epithelial cell injury, and upregulated the
levels of colonic tight junction proteins ZO-1, claudin-1,
and occluding. In the in vitro study, the formononetin prevented acute injury of human colonic cells by increasing
colonic tight junction proteins and decreasing inﬂammatory cytokine expression. The mechanism may partly be
associated with NLRP3 inﬂammasome signaling inhibition,
as the NLRP3 pathway protein levels including NLRP3,
ASC, and interleukin-1β were downregulated in a dosedependent manner, in vivo and in vitro, when formononetin
was administered. The authors concluded that formononetin could protect colonic epithelial cells from injury to
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relieve the disease severity of colitis and may have potential to be used in the clinical prevention and treatment of
IBD in future.
Angiostrongylosis is an important food-borne diseases
and eosinophilic encephalitis in humans, caused by rat
gut nematode (rat lungworm). Outbreaks of eosinophilic
meningitis have been reported due to the consumption
of infected raw snails and vegetables’ juice. Angiostrongylus invades the central nervous system and causes neurons’
demyelination, eosinophilic encephalitis, and meningoencephalitis. An inﬂammatory response and surge of cytokines
such as IL-17 have been detected in the central nervous
system. IL-17 can induce Act1-mediated signaling cascades
in CNS resident cells (astrocytes, oligodendrocytes, and neurons) might coordinately mediate CNS inﬂammation, demyelination, and neurodegeneration. But the mechanisms by
which IL-17 involves in the demyelination caused by this
nematode is not investigated. F. Ying et al. explore the role
of IL-17A on the demyelination and introduce IL-17Aneutralizing antibody to protect against demyelination
caused by the parasite as a possible therapeutic option in
angiostrongylosis. In addition, iNOS inhibition is the possible mechanism for the therapeutic eﬀect. This study provides
a new potential therapeutic alternative for demyelination
caused by Angiostrongylus cantonensis.
Alcohol consumption in excess causes extensive liver
injuries of fatty liver which progresses to hepatitis, ﬁbrosis,
cirrhosis, and hepatocarcinoma. Ethanol increases NADH/
NAD+ ratio and promotes fatty acid synthesis and lipid
accumulation in liver cells. Further, it causes excessive oxidative stress and increases CYP2E1 activity. In addition,
ethanol increases endotoxin bypass from leaky gut which
triggers Kupﬀer’s cell activation and inﬂammatory processes. There is an emerging theory that chronic ethanol
abuse damages the tight junction structure in intestinal
epithelial cells results in bacterial translocation from the
intestines into the in vivo circulation to induce hepatic
inﬂammation. Indeed, patients with alcoholic liver disease
have higher levels of endotoxin and intestinal barrier disturbances caused by ethanol are the major source of endotoxemia in these patients. Diﬀerent source of dietary fat
can eﬀect progression of liver injury as diets rich in saturated fatty acids or medium chain triglycerides protect
against ethanol-induced liver injury in rodents. In contrast,
polyunsaturated fatty acids can provoke liver injury. However, there were some limitations of these previous studies
such as only one type of fat was used in each experimental
diet, but the eﬀects on other organs or tissues were not
explored. Studies have demonstrated that ﬁsh oil, which
is rich in n-3 polyunsaturated fatty acids, eicosapentaenoic
acid, and docosahexaenoic acid, can provide immune regulation, vascular protection, and lipid metabolism modulation. However, the mechanism by which oil can modify
intestinal integrity in alcoholic liver disease is not well
understood. Further, some studies reveal ﬁsh oil and olive
oil to improve the fecal microbiota under ethanol exposure, but the eﬀects on intestinal pathological changes in
ethanol-fed rats are still unclear. Y.-W. Chien et al.
explored whether ﬁsh oil can provoke hepatoprotective
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eﬀects in ethanol-fed rats by means of maintaining the
epithelial barrier function in the intestines and further inhibiting endotoxin in circulation. Authors concluded that
the chronic ethanol can elevate plasma endotoxin concentrations and trigger inﬂammatory responses which can
result in liver injury. Substitution of ﬁsh oil for olive oil
inhibited the appearance of endotoxin in the circulation
under ethanol exposure; thus, it decreased inﬂammatory
responses and exerted a hepatoprotective potential in rats
under chronic ethanol feeding. However, the mechanism
of decreased plasma endotoxin levels by ﬁsh oil supplementation alone might not be enough to improve intestinal structural integrity.
About 30–40% of chronic inﬂammatory disease patients
use some form of complementary and alternative medicine,
including Chinese traditional herbal therapies. It is estimated that 12 million tons of herbal wastes is produced each
year by about 1,500 Chinese traditional herbal medicine
enterprises in China. During process, the active ingredients
are extracted from plants, and the waste which still contains
about 30%–50% of the medicinal active ingredient is buried
or burned which becomes major source of environmental
pollutant in water and in air. Fermentation by digestive
enzymatic reaction utilizing cellulase, protease, pectinase,
and lipase can degrade plant cell wall and expose intercellular organelles to assist in extraction of active ingredients. In
addition, certain probiotics can improve digestive process
and protect against malabsorption, malnutrition, and diarrhea. Antibiotic-associated diarrhea is a frequent side eﬀect
caused by altered gut microbiota which supports pathogen
growth. F. Meng et al. used probiotics to ferment the
herbal residues in Jianweixiaoshi, a mixture of herbal remedy used for diarrhea, and the reason for this compound
may become as therapeutic potential against antibioticassociated diarrhea, as well as to reduce the waste products
from herbal residues produced by traditional herbal medicine enterprises.
Flowers of Osmanthus fragrans (O. fragrans) and Chrysanthemum morifolium (C. morifolium) are commonly used
as folk medicine and additives for tea and beverages. The
active components isolated from these ﬂowers contain many
phenolic compounds that have been shown to have antiinﬂammatory and antioxidant properties. Lipotoxicity occurs
when excessive harmful lipid accumulates in cells leading
to cellular dysfunction and disruption of tissue function.
Lipotoxicity plays a critical role in the pathogenesis of
nonalcoholic fatty liver disease and renal diseases. P.-J.
Tsai et al. investigated the eﬀects of methanolic ﬂower
extracts of O. fragrans and C. morifolium against free fatty
acid-induced lipotoxicity in hepatocytes and renal glomerular mesangial cells. The results showed that both extracts
inhibited free fatty acid-induced hepatocyte triglyceride
accumulation and suppressed mRNA expression of inﬂammatory cytokines when hepatocytes were stimulated with
lipopolysaccharide-treated monocytes. Also, ﬂowers extracts
of O. fragrans and C. morifolium eﬀectively inhibited oleateinduced cellular lipid accumulation and overexpression of
ﬁbronectin in mesangial cells. The authors concluded that
these ﬂower extracts possess hepato- and renal-protective

Mediators of Inﬂammation
activity by inhibiting hepatic fat load and inﬂammation
and mesangial extracellular matrix formation. These ﬁndings imply that ﬂowers of O. fragrans and C. morifolium
may have potential to protect against nonalcoholic steatohepatitis and renal ﬁbrosis.
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